Creating Your DNA-Based "Digital Twin"
Predictiv assesses your risk level for more than 16,000 diseases — using just your fingernail.
The company uses your nail to extract your DNA and sequence it. It then analyzes it to create what it calls your “Digital Twin,” which is a virtual profile of your DNA. In doing so, it can assess your level of risk for potentially life-threatening diseases, and also simulate your body’s reaction to more than 300 drugs.
Predictiv’s team has experience at the National Institutes of Health, Johns Hopkins, and Pfizer. The company has received an investment from Plug & Play Ventures, a Silicon Valley-based venture capital fund, and has filed for two patents.
In 2020, Predictiv completed a “beta” version of its technology and aims to begin generating revenue this year.
Seed-and-early-stage investment firm. 150 portfolio companies in Web 2.0, Software (SaaS), Social Media, Gaming, Enterprise, Cloud, and Telecom.